Annual Total Liabilities
$346.77 M
-$20.81 M-5.66%
31 December 2023
Summary:
CRISPR Therapeutics AG annual total liabilities is currently $346.77 million, with the most recent change of -$20.81 million (-5.66%) on 31 December 2023. During the last 3 years, it has risen by +$183.04 million (+111.79%). CRSP annual total liabilities is now -5.66% below its all-time high of $367.58 million, reached on 31 December 2022.CRSP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$316.47 M
-$42.43 M-11.82%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly total liabilities is currently $316.47 million, with the most recent change of -$42.43 million (-11.82%) on 30 September 2024. Over the past year, it has dropped by -$42.56 million (-11.86%). CRSP quarterly total liabilities is now -20.76% below its all-time high of $399.40 million, reached on 30 September 2022.CRSP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.7% | -11.9% |
| 3 y3 years | +111.8% | +2.5% |
| 5 y5 years | +258.1% | +145.9% |
CRSP Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.7% | +111.8% | -20.8% | +2.5% |
| 5 y | 5 years | -5.7% | +258.1% | -20.8% | +161.1% |
| alltime | all time | -5.7% | +3979.1% | -20.8% | +278.9% |
CRISPR Therapeutics AG Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $316.47 M(-11.8%) |
| June 2024 | - | $358.90 M(+1.1%) |
| Mar 2024 | - | $355.08 M(+2.4%) |
| Dec 2023 | $346.77 M(-5.7%) | $346.77 M(-3.4%) |
| Sept 2023 | - | $359.04 M(-5.8%) |
| June 2023 | - | $380.99 M(-2.2%) |
| Mar 2023 | - | $389.47 M(+6.0%) |
| Dec 2022 | $367.58 M(+4.3%) | $367.58 M(-8.0%) |
| Sept 2022 | - | $399.40 M(+7.2%) |
| June 2022 | - | $372.53 M(+3.1%) |
| Mar 2022 | - | $361.26 M(+2.5%) |
| Dec 2021 | $352.42 M(+115.2%) | $352.42 M(+14.1%) |
| Sept 2021 | - | $308.80 M(+4.4%) |
| June 2021 | - | $295.72 M(+94.0%) |
| Mar 2021 | - | $152.41 M(-6.9%) |
| Dec 2020 | $163.73 M | $163.73 M(+15.5%) |
| Sept 2020 | - | $141.72 M(+4.3%) |
| June 2020 | - | $135.86 M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $121.20 M(-4.8%) |
| Dec 2019 | $127.33 M(+31.5%) | $127.33 M(-1.1%) |
| Sept 2019 | - | $128.71 M(+1.7%) |
| June 2019 | - | $126.56 M(+7.2%) |
| Mar 2019 | - | $118.06 M(+21.9%) |
| Dec 2018 | $96.82 M(+15.9%) | $96.82 M(-4.7%) |
| Sept 2018 | - | $101.59 M(+15.5%) |
| June 2018 | - | $87.98 M(+4.6%) |
| Mar 2018 | - | $84.12 M(+0.7%) |
| Dec 2017 | $83.51 M(-25.5%) | $83.51 M(-19.2%) |
| Sept 2017 | - | $103.36 M(-3.6%) |
| June 2017 | - | $107.17 M(+0.0%) |
| Mar 2017 | - | $107.17 M(-4.4%) |
| Dec 2016 | $112.12 M(-40.5%) | $112.12 M(-67.1%) |
| Sept 2016 | - | $341.19 M(+116.3%) |
| June 2016 | - | $157.72 M(-16.4%) |
| Dec 2015 | $188.55 M(+2117.9%) | $188.55 M |
| Dec 2014 | $8.50 M | - |
FAQ
- What is CRISPR Therapeutics AG annual total liabilities?
- What is the all time high annual total liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual total liabilities year-on-year change?
- What is CRISPR Therapeutics AG quarterly total liabilities?
- What is the all time high quarterly total liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly total liabilities year-on-year change?
What is CRISPR Therapeutics AG annual total liabilities?
The current annual total liabilities of CRSP is $346.77 M
What is the all time high annual total liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total liabilities is $367.58 M
What is CRISPR Therapeutics AG annual total liabilities year-on-year change?
Over the past year, CRSP annual total liabilities has changed by -$20.81 M (-5.66%)
What is CRISPR Therapeutics AG quarterly total liabilities?
The current quarterly total liabilities of CRSP is $316.47 M
What is the all time high quarterly total liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total liabilities is $399.40 M
What is CRISPR Therapeutics AG quarterly total liabilities year-on-year change?
Over the past year, CRSP quarterly total liabilities has changed by -$42.56 M (-11.86%)